May 1, 2024 Inflation Persistence: No Fed Rate Cuts in Sight
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
3M Stock: Dividend Likely Cut In Half
Amazon Q1 Review: Best Of Big Tech Bunch
Tesla: The Thesis Is Stronger Than Ever
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Charles River Laboratories International (CRL) Stock Forecast for 2024–2028. Sell or Buy?
Updated: May 2, 2024 (13:07)
Sector: HealthcareThe share price of Charles River Laboratories International, Inc. (CRL) now
50/200 Day Moving Average: $252.38 / $216.7
This figure corresponds to the Average Price over the previous 50/200 days. For Charles River Laboratories International stocks, the 50-day moving average is the resistance level today.
For Charles River Laboratories International stocks, the 200-day moving average is the support level today.
Are you interested in Charles River Laboratories International, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Charles River Laboratories International stock price in 2024, 2025, 2026, 2027, 2028. How much will one Charles River Laboratories International share be worth in 2024 - 2028?
When should I take profit in Charles River Laboratories International stock? When should I record a loss on Charles River Laboratories International stock? What are analysts' forecasts for Charles River Laboratories International stock? What is the future of Charles River Laboratories International stock? We forecast Charles River Laboratories International stock performance using neural networks based on historical data on Charles River Laboratories International stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Charles River Laboratories International stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Charles River Laboratories International shares. This happens once a day.
Historical and forecast chart of Charles River Laboratories International stock
The chart below shows the historical price of Charles River Laboratories International stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Charles River Laboratories International stock price can be found in the table below.
Long-term forecasts by years.
Charles River Laboratories International, Inc., an early stage contract research company, provides drug discovery, non-clinical development and safety testing services in the United States, Europe, Canada, Asia Pacific and worldwide. It operates across three segments: Research Models and Services (RMS), Security Discovery and Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment manufactures and markets lines of research models and specially bred rats and mice for use by researchers.
Charles River Laboratories International daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 04 | 232.71 | 231.53 | 233.92 | 1.04 |
| May 05 | 232.57 | 231.97 | 233.11 | 0.49 |
| May 06 | 230.25 | 228.96 | 231.17 | 0.97 |
| May 07 | 229.63 | 227.97 | 230.20 | 0.98 |
| May 08 | 230.22 | 229.30 | 231.76 | 1.07 |
| May 09 | 231.12 | 229.90 | 231.88 | 0.86 |
| May 10 | 230.98 | 229.83 | 231.54 | 0.74 |
| May 11 | 231.33 | 229.73 | 232.18 | 1.07 |
| May 12 | 229.22 | 227.53 | 230.48 | 1.30 |
| May 13 | 229.54 | 228.05 | 230.94 | 1.27 |
| May 14 | 228.35 | 227.62 | 229.38 | 0.77 |
| May 15 | 230.09 | 229.37 | 231.03 | 0.72 |
| May 16 | 231.24 | 230.20 | 232.18 | 0.86 |
| May 17 | 231.68 | 230.59 | 232.83 | 0.97 |
| May 18 | 233.11 | 231.60 | 234.74 | 1.36 |
| May 19 | 233.95 | 232.62 | 235.31 | 1.16 |
| May 20 | 236.01 | 234.12 | 237.71 | 1.53 |
| May 21 | 237.10 | 236.31 | 238.99 | 1.13 |
| May 22 | 237.76 | 236.19 | 238.35 | 0.92 |
| May 23 | 238.59 | 237.92 | 239.98 | 0.86 |
| May 24 | 239.35 | 238.09 | 240.22 | 0.89 |
| May 25 | 238.68 | 237.90 | 239.66 | 0.74 |
| May 26 | 237.61 | 235.71 | 238.97 | 1.38 |
| May 27 | 236.47 | 235.29 | 237.42 | 0.90 |
| May 28 | 235.41 | 234.06 | 236.87 | 1.20 |
| May 29 | 234.49 | 232.94 | 235.64 | 1.16 |
| May 30 | 232.52 | 231.82 | 233.24 | 0.61 |
| May 31 | 230.73 | 230.27 | 232.53 | 0.98 |
| Jun 01 | 229.92 | 229.46 | 230.59 | 0.49 |
| Jun 02 | 230.43 | 229.23 | 232.18 | 1.29 |
Charles River Laboratories International Daily Price Targets
Charles River Laboratories International Stock Forecast 05-04-2024.
Forecast target price for 05-04-2024: $232.71.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.025%.
Pessimistic target level: 231.53
Optimistic target level: 233.92
Charles River Laboratories International Stock Forecast 05-05-2024.
Forecast target price for 05-05-2024: $232.57.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 0.489%.
Pessimistic target level: 231.97
Optimistic target level: 233.11
Charles River Laboratories International Stock Forecast 05-06-2024.
Forecast target price for 05-06-2024: $230.25.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 0.956%.
Pessimistic target level: 228.96
Optimistic target level: 231.17
Charles River Laboratories International Stock Forecast 05-07-2024.
Forecast target price for 05-07-2024: $229.63.
Negative dynamics for Charles River Laboratories International shares will prevail with possible volatility of 0.967%.
Pessimistic target level: 227.97
Optimistic target level: 230.20
Charles River Laboratories International Stock Forecast 05-08-2024.
Forecast target price for 05-08-2024: $230.22.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 1.063%.
Pessimistic target level: 229.30
Optimistic target level: 231.76
Charles River Laboratories International Stock Forecast 05-09-2024.
Forecast target price for 05-09-2024: $231.12.
Positive dynamics for Charles River Laboratories International shares will prevail with possible volatility of 0.857%.
Pessimistic target level: 229.90
Optimistic target level: 231.88
CRL (CRL) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 228.36 | 216.69 | 237.31 | 8.69 |
| Jul. | 242.59 | 231.21 | 252.77 | 8.53 |
| Aug. | 249.89 | 242.54 | 261.26 | 7.16 |
| Sep. | 235.02 | 227.62 | 245.05 | 7.12 |
| Oct. | 230.41 | 221.38 | 239.77 | 7.67 |
| Nov. | 238.96 | 235.28 | 246.15 | 4.42 |
| Dec. | 243.65 | 232.39 | 250.98 | 7.41 |
Charles River Laboratories International forecast for this year
Charles River Laboratories International Stock Prediction for Jun 2024
An downtrend is forecast for this month with an optimal target price of $228.359. Pessimistic: $216.69. Optimistic: $237.31
Charles River Laboratories International Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $242.586. Pessimistic: $231.21. Optimistic: $252.77
Charles River Laboratories International Stock Prediction for Aug 2024
An uptrend is forecast for this month with an optimal target price of $249.887. Pessimistic: $242.54. Optimistic: $261.26
Charles River Laboratories International Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $235.019. Pessimistic: $227.62. Optimistic: $245.05
Charles River Laboratories International Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $230.413. Pessimistic: $221.38. Optimistic: $239.77
Charles River Laboratories International Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $238.961. Pessimistic: $235.28. Optimistic: $246.15
Charles River Laboratories International Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $243.645. Pessimistic: $232.39. Optimistic: $250.98
Charles River Laboratories International (CRL) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 236.82 | 230.69 | 243.45 | 5.24 |
| Feb | 235.17 | 230.56 | 245.04 | 5.91 |
| Mar | 236.48 | 230.36 | 245.75 | 6.26 |
| Apr | 233.83 | 230.07 | 245.95 | 6.46 |
| May | 221.56 | 213.34 | 227.92 | 6.40 |
| Jun | 215.04 | 206.46 | 222.57 | 7.24 |
| Jul | 211.73 | 201.95 | 222.11 | 9.08 |
| Aug | 207.29 | 202.64 | 213.09 | 4.90 |
| Sep | 203.66 | 193.68 | 209.22 | 7.43 |
| Oct | 211.93 | 205.84 | 216.08 | 4.74 |
| Nov | 216.53 | 213.34 | 227.14 | 6.07 |
| Dec | 216.68 | 212.43 | 221.83 | 4.24 |
Charles River Laboratories International (CRL) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 209.40 | 204.85 | 214.67 | 4.57 |
| Feb | 200.60 | 189.51 | 205.66 | 7.85 |
| Mar | 203.41 | 200.56 | 213.09 | 5.88 |
| Apr | 199.85 | 195.37 | 208.52 | 6.31 |
| May | 204.33 | 198.03 | 213.34 | 7.17 |
| Jun | 212.62 | 202.35 | 220.66 | 8.30 |
| Jul | 208.60 | 199.41 | 218.24 | 8.63 |
| Aug | 205.54 | 202.52 | 210.43 | 3.76 |
| Sep | 193.60 | 186.68 | 199.02 | 6.20 |
| Oct | 186.55 | 183.55 | 191.64 | 4.22 |
| Nov | 186.42 | 177.15 | 192.29 | 7.87 |
| Dec | 186.55 | 177.28 | 191.12 | 7.24 |
Charles River Laboratories International (CRL) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 184.72 | 180.07 | 190.28 | 5.37 |
| Feb | 195.07 | 184.96 | 203.53 | 9.12 |
| Mar | 204.35 | 197.91 | 213.79 | 7.43 |
| Apr | 206.78 | 203.89 | 218.36 | 6.63 |
| May | 207.65 | 201.98 | 216.23 | 6.59 |
| Jun | 210.70 | 203.48 | 218.37 | 6.82 |
| Jul | 223.98 | 217.24 | 229.62 | 5.39 |
| Aug | 239.03 | 229.32 | 245.22 | 6.48 |
| Sep | 237.36 | 232.87 | 246.99 | 5.72 |
| Oct | 222.07 | 210.41 | 226.58 | 7.14 |
| Nov | 215.23 | 203.93 | 224.72 | 9.25 |
| Dec | 214.33 | 209.53 | 224.38 | 6.62 |
Charles River Laboratories International (CRL) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 228.13 | 222.06 | 231.80 | 4.20 |
| Feb | 234.68 | 222.52 | 244.53 | 9.00 |
| Mar | 242.89 | 233.54 | 249.86 | 6.53 |
| Apr | 248.67 | 244.67 | 259.29 | 5.64 |
| May | 240.14 | 233.59 | 251.91 | 7.27 |
| Jun | 247.87 | 244.06 | 257.59 | 5.25 |
| Jul | 252.39 | 245.32 | 265.64 | 7.65 |
| Aug | 252.74 | 247.43 | 262.65 | 5.79 |
| Sep | 238.59 | 234.91 | 246.10 | 4.55 |
| Oct | 241.76 | 238.37 | 247.17 | 3.56 |
| Nov | 229.40 | 217.36 | 239.20 | 9.13 |
| Dec | 228.92 | 224.28 | 234.69 | 4.44 |
Charles River Laboratories International information and performance
251 BALLARDVALE ST, WILMINGTON, MA, US
Market capitalization of the Charles River Laboratories International, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRL shares in the company outstanding by the market price of one share.
EBITDA of Charles River Laboratories International is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
